Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium

NCT01288404 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Pterygium of the Conjunctiva and Cornea

Interventions

DRUG: Fluorometholone
DRUG: Bevacizumab
DRUG: Bevacizumab
DRUG: Bevacizumab

Sponsor

Ramathibodi Hospital